Lithium Ion

Lithium Ion

SCHEMBL30908313

O=C([O-])c1cnc(C2CCC2)nc1.[Li+]

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 2/20 0.36
HIPK2 Q9H2X6 2/20 0.34
HDAC4 P56524 1/20 0.34
KDM4E B2RXH2 1/20 0.33
GLA P06280 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HIF1A Q16665 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
P4HTM Q9NXG6 1/20 0.33
HSD11B1 P28845 2/20 0.32
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4636092 0.76 KDM4E (0.49) HCAR3HDAC4KDM4EGLAHTT
Lithium Ion SCHEMBL20589049 0.73 HPGDS (0.54) HIPK2
SCHEMBL1714095 0.72 HCAR3 (0.46) HCAR3HDAC4KDM4EGLAHTT
SCHEMBL12791697 0.71 MAPK1 (0.46) KDM4EKMT2ASMN1; SMN2L3MBTL1
SCHEMBL30908327 0.71 CSNK1D (0.48)
SCHEMBL17294856 0.71 NNMT (0.44) HDAC4KDM4ESMN1; SMN2L3MBTL1HSD11B1
SCHEMBL12640243 0.71 HDAC4 (0.40) HDAC4
Lithium Ion SCHEMBL16047036 0.69 HDAC1 (0.55) HCAR3HIPK2KDM4EHDAC3HDAC1
SCHEMBL24755952 0.67 TDO2 (0.36) HDAC4KDM4EGLAHTTKMT2A
SCHEMBL11230605 0.67 DEGS1 (0.37) HDAC4KDM4EGLAHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024074611-A1 PRMT5 INHIBITORS Ryvu Therapeutics S.A. (PL) 2024-04-11 WO disclosed